Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 56 | 56 | 0 |
| Shares | 2.30M | 5.16M | +2.86M (+124.7%) |
| Value | $5.99M | $11.9M | +$5.92M (+98.9%) |
New holders (9)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Murchinson Ltd. | 1,050,000 | $2.43M | 0.46% |
| Boothbay Fund Management, LLC | 525,001 | $1.21M | 0.05% |
| D. E. Shaw & Co., Inc. | 59,070 | $136.5K | 0.00% |
| Citadel Advisors LLC | 31,347 | $72.4K | 0.00% |
| XTX Topco Ltd | 17,325 | $40.0K | 0.01% |
| HRT Financial LP | 11,165 | $25.0K | 0.00% |
| AJOVista, LLC | 8,390 | $19.4K | 0.02% |
| LM Advisors LLC | 2,500 | $5.78K | 0.00% |
| Global Retirement Partners, LLC | 100 | $228 | 0.00% |
Sold out (9)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Goldman Sachs Group Inc | 153,618 | $400.9K |
| Gsa Capital Partners LLP | 88,923 | $232.0K |
| Citigroup Inc | 41,471 | $108.2K |
| Dimensional Fund Advisors LP | 27,285 | $71.2K |
| Virtu Financial LLC | 17,388 | $45.0K |
| Prudential Financial Inc | 11,200 | $29.2K |
| Invesco Ltd. | 10,094 | $26.3K |
| Simplex Trading, LLC | 2,496 | $6.00K |
| TD Waterhouse Canada Inc. | 1,000 | $2.55K |